Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

ClinicalTrials.gov ID: NCT03977155

Public ClinicalTrials.gov record NCT03977155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to evaluate in participants with diarrhea-predominant Irritable Bowel Syndrome (IBS-D) the abdominal pain response to BOS-589 after 4 weeks of treatment and to evaluate the overall safety and tolerability of BOS-589 in the treatment of IBS-D during 4 weeks of treatment, relative to placebo (PBO).

Study identification

NCT ID
NCT03977155
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boston Pharmaceuticals
Industry
Enrollment
133 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2019 (Actual)
Primary completion
May 6, 2020 (Actual)
Completion
May 6, 2020 (Actual)
Last update posted
Jun 7, 2021

2019 – 2020

United States locations

U.S. sites
58
U.S. states
23
U.S. cities
51
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207 —
Clinical Research Associates Huntsville Alabama 35801 —
Synexus Clinical Research US, Inc. - East Valley Family Physicians, PLC Chandler Arizona 85224 —
Synexus Clinical Research US, Inc. - Phoenix Southeast Chandler Arizona 85224 —
Synexus Clinical Research US, Inc. - Desert Clinical Research, LLC Mesa Arizona 85018 —
Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC Mesa Arizona 85213 —
Hope Research Institute LLC Peoria Arizona 85381 —
Elite Clinical Studies Phoenix Arizona 85018 —
Synexus Clinical Research US, Inc. - Tatum Highlands Medical Associates, PLLC Phoenix Arizona 85050 —
Hope Research Institute LLC Phoenix Arizona 85206 —
Arkansas Gastroenterology North Little Rock Arkansas 72117 —
Synexus Clinical Research US, Inc. Carlsbad California 95821 —
Paragon Rx Clinical, Inc. Garden Grove California 92683 —
eStudySite La Mesa California 91942 —
Grossmont Center For Clinical Research La Mesa California 92008 —
Clinical Trials Research Sacramento California 91942 —
Research and Education Inc San Diego California 92105 —
Precision Research Institute San Diego California 92114 —
Shahram Jacobs MD Inc Sherman Oaks California 91403 —
Millennium ClinicalTrials Thousand Oaks California 92840 —
Advanced Rx Clinical Research Westminster California 91360 —
Chase Medical Research LLC Waterbury Connecticut 06708 —
PAB Clinical Research-ClinEdge-PPDS Brandon Florida 33511 —
Nature Coast Clinical Research LLC - ERN-PPDS Inverness Florida 34452 —
Mayo Clinic Jacksonville Florida 32224 —
Health Awareness Inc Jupiter Florida 33458 —
Suncoast Research Group LLC - ERN-PPDS Miami Florida 33135 —
Ormond Medical Arts Pharmaceutical Ormond Beach Florida 32174 —
Precision Clinical Research, LLC Sunrise Florida 33351 —
Northwest Clinical Trials-ClinEdge-PPDS Boise Idaho 83704 —
Synexus Clinical Research US, Inc. - Allaw Evansville Indiana 47714 —
Boston Clinical Trials Inc Boston Massachusetts 02131 —
West Michigan Clinical Research Wyoming Michigan 49519 —
Sundance Clinical Research St Louis Missouri 63141 —
Quality Clinical Research - ClinEdge - PPDS Omaha Nebraska 68114 —
Albuquerque Clinical Trials Inc - BTC - PPDS Albuquerque New Mexico 87102 —
NY Scientific Brooklyn New York 11235 —
Peters Medical Research, LLC High Point North Carolina 27262 —
PMG Research of Raleigh, LLC Raleigh North Carolina 27609 —
Synexus Clinical Research US, Inc. Akron Ohio 44311 —
Hometown Urgent Care and Research Cincinnati Ohio 45215 —
Synexus Clinical Research US, Inc. Columbus Ohio 45424 —
Hometown Urgent Care and Research Dayton Ohio 43212 —
Founders Research Corporation Philadelphia Pennsylvania 19114 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Safe Harbor Clinical Research East Providence Rhode Island 02914 —
Synexus Clinical Research US, Inc. Anderson South Carolina 29621 —
Pledmont Research Partners LLC Fort Mill South Carolina 29707 —
Synexus Clinical Research US, Inc. Greer South Carolina 29651 —
WR-ClinSearch, LLC Chattanooga Tennessee 37909 —
New Phase Research & Development Knoxville Tennessee 37421 —
L12 Clinical Research Dallas Texas 75219 —
Synexus Clinical Research US, Inc. Dallas Texas 78209 —
Southwest Clinical Trials Houston Texas 77074 —
Quality Research Inc. San Antonio Texas 75234 —
Advanced Research Institute Ogden Utah 84405 —
Blue Ridge Medical Research Lynchburg Virginia 24502 —
Clinical Research Partners LLC Richmond Virginia 23235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03977155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2021 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03977155 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →